Suchergebnisse - "Antoniadou, Anastasia"

PubPharm (9)

1

Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria : relevance to external validity

enthalten in: BMC infectious diseases | 2021

von Daitch, V. | Paul, M. | Daikos, G. | +27

2

Colistin Resistance Development Following Colistin-Meropenem Combination Therapy Versus Colistin Monotherapy in Patients With Infections Caused by Carbapenem-Resistant Organisms

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2020

von Dickstein, Y. | Lellouche, J. | Schwartz, D. | +71

3

Colistin plus meropenem for carbapenem-resistant Gram-negative infections : in vitro synergism is not associated with better clinical outcomes

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2020

von Nutman, A. | Lellouche, J. | Temkin, E. | +67

CommentIn: Clin Microbiol Infect. 2020 Sep;26(9):1274. - PMID 32389843

4

Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections : An Exploratory Subgroup Analysis of a Randomized Clinical Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2019

von Dickstein, Y. | Lellouche, J. | Ben Dalak Amar, M. | +65

CommentIn: Clin Infect Dis. 2020 Aug 22;71(5):1358-1359. - PMID 31734694

5

The Association Between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-resistant Gram-negative Bacteria : A Prospective Study

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2018

von Zak-Doron, Y. | Dishon Benattar, Y. | Pfeffer, I. | +63

6

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria : an open-label, randomised controlled trial

enthalten in: The Lancet. Infectious diseases | 2018

von Paul, M. | Daikos, G. | Durante-Mangoni, E. | +24

CommentIn: Lancet Infect Dis. 2018 Apr;18(4):358-360. - PMID 29456042

7

Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA) : a study protocol

enthalten in: BMJ open | 2016

von Dickstein, Y. | Leibovici, L. | Yahav, D. | +22

8

Application of a loading dose of colistin methanesulfonate in critically ill patients : population pharmacokinetics, protein binding, and prediction of bacterial kill

enthalten in: Antimicrobial agents and chemotherapy | 2012

von Mohamed, A. | Karaiskos, I. | Plachouras, D. | +9

9

Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients : first report of a multiclonal cluster

enthalten in: The Journal of antimicrobial chemotherapy | 2007

von Antoniadou, A. | Kontopidou, F. | Poulakou, G. | +7

1
[1]